Trial intelligence / Profile preview

Tacrolimus with or without MMF in Pediatric Liver Transplantation

NCT00195988Phase 4Completed

Sponsor
Children's Memorial Health Institute
Start
Sep 2002
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of mycophenolate mofetil in Liver transplant rejection (2 arms), sponsored by Children's Memorial Health Institute. Primary endpoints: Number of rejections at 1 year and Number of steroid-resistant rejections at 1 year. Started Sep 2002; status: completed.

02

Drugs

mycophenolate mofetil
03

Conditions

Liver transplant rejection

Beyond the preview

Go deeper on NCT00195988.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00195988.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call